The Treatment of Peyronie's Disease with Tamoxifen
- 1 December 1992
- journal article
- Published by Wiley
- Vol. 70 (6), 648-651
- https://doi.org/10.1111/j.1464-410x.1992.tb15836.x
Abstract
Summary This is a preliminary study of the treatment of 36 patients with Peyronie's disease who received tamoxifen 20 mg twice daily for 3 months. An improvement occurred in 16 of 20 patients with penile pain, in 11 of 31 patients with an erectile deformity and 12 of 35 patients had a plaque shrinkage of at least 1 cm. Some improvement occurred in 6 of the 8 patients with a histologically confirmed inflammatory infiltrate of the plaque but not in any of the 4 patients without an infiltrate. The inflammatory infiltrate was found in patients in whom the duration of the disease was less than 4 months.Keywords
This publication has 6 references indexed in Scilit:
- Pre‐operative Assessment of Peyronie's Disease Using Colour Doppler SonographyBritish Journal of Urology, 1992
- Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblastsBritish Journal of Cancer, 1990
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989
- Classification of Congenital and Acquired Penile DeviationUrologia Internationalis, 1983
- Factors Associated in the Aetiology of Peyronie's DiseaseBritish Journal of Urology, 1982
- Procarbazine (Natulan) in the Treatment of Peyronie's DiseaseBritish Journal of Urology, 1978